Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Macrocyclics, Roche in Nuclear Medicine Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Macrocyclics, Roche in Nuclear Medicine Pact

Aims to speed up the clinical development process

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Macrocyclics has entered a new collaborative research agreement with Roche for the continued development of novel chelating agents designed by Macrocyclics for Roche’s applications. The collaboration aims to speed up the clinical development process. The new project will build on established progress related to lead-212 (212Pb) and novel chelate architecture for radioimmunotherapy. 
 
“We are privileged to be working with the world leader in oncology and antibody technology and are excited to contribute in the development of powerful new therapies based on lead-212,” said Garry Kiefer, chief executive officer of Macrocyclics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics